aTyr Pharma, Inc. ( ATYR) - Stock Earnings
ATYR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -25.7 million USD | 190000 USD |
| 2025Q4 | -14.0 million USD | — USD |
| 2026Q1 | -10.8 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ATYR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -50.4 million USD | 353000 USD |
| 2024 | -64.0 million USD | 235000 USD |
| 2025 | -74.1 million USD | 190000 USD |
| 2026 Est. | — | — |
ATYR
Price: $0.45
52 week price:
Earnings Per Share: -0.74 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 50.3 million